Alterity Therapeutics
(OTC) PRNAF
Alterity Therapeutics Financials at a Glance
Market Cap
$239.30K
Revenue (TTM)
A$5.64M
Net Income (TTM)
-A$44.51M
EPS (TTM)
-$0.05
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.06
Volume
100
Open
$0.06
Price
$0.06
Volume
100
Open
$0.06
Previous Close
$0.06
Daily Range
$0.06 - $0.06
52-Week Range
$0.00 - $0.54
Estimated Earnings Date
Aug 28, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.06
Volume
100
Open
$0.06
Previous Close
$0.06
Daily Range
$0.06 - $0.06
52-Week Range
$0.00 - $0.54
Estimated Earnings Date
Aug 28, 2026
PRNAF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alterity Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
David A. Stamler, MD
Website
www.alteritytherapeutics.comHeadquarters
Melbourne, VIC 3000, AU
PRNAF Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-5%
Net Income Margin
-4%
Return on Equity
-46%
Return on Capital
-37%
Return on Assets
-26%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$239.30K
Shares Outstanding
217.51M
Volume
100
Avg. Volume
179.624
Financials (TTM)
Gross Profit
A$5.31M
Operating Income
-A$14.57M
EBITDA
-A$14.63M
Operating Cash Flow
-A$11.45M
Capital Expenditure
-A$1.00
Free Cash Flow
-A$11.45M
Cash & ST Invst.
A$40.66M
Total Debt
A$155.46K
Alterity Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
A$0.00
-100.0%
Gross Profit
-A$57.87K
-103.2%
Gross Margin
0.00%
N/A
Market Cap
$239.30K
N/A
Market Cap/Employee
$23.93K
N/A
Employees
10
N/A
Net Income
-A$9.61M
-257.3%
EBITDA
-A$12.99M
-96.8%
Quarterly Fundamentals
Total Cash
A$49.18M
+299.2%
Total Debt
A$98.45K
-61.5%
Accounts Receivable
A$6.84M
+17.8%
Inventory
A$0.00
N/A
Long Term Debt
A$130.87K
+71.1%
Short Term Debt
A$32.99K
-81.6%
Return on Assets
-25.63%
N/A
Return on Invested Capital
-37.08%
N/A
Free Cash Flow
-A$4.73M
-5.1%
Operating Cash Flow
-A$10.62M
-136.2%